Page 64 - ITPS-8-1
P. 64
INNOSC Theranostics and
Pharmacological Sciences Opioid use among Nigerian students
doi: 10.58729/1941-6687.1106 doi: 10.1503/cmaj.109-4085
52. Ebigbo PO, Elekwachi CL, Nweze CF. Challenges in the 63. Martins S, Fenton M, Keyes K, Blanco C, Zhu H, Storr C.
treatment of drug misuse in a Nigerian female health worker: Mood and anxiety disorders and their association with non-
A case study applying the Wawa technique. J Contemp medical prescription opioid use and prescription opioid-
Psychother. 2012;42(4):257-264. use disorder: longitudinal evidence from the national
doi: 10.1007/s10879-012-9213-9 epidemiologic study on alcohol and related conditions.
Psychol Med. 2011;42(6):1261-1272.
53. Molobe ID. Human rights misuse experienced by people
who use drugs. A Nigeria-focused review. Int J Med Surg Sci. doi: 10.1017/s0033291711002145
2019;6(4):133-135. 64. Gilson A, Maurer M, Ryan K, Rathouz P, Cleary J. Using
doi: 10.32457/ijmss.2019.039 a morphine equivalence metric to quantify opioid
consumption: Examining the capacity to provide effective
54. NAFDAC - National Agency for Food and Drugs treatment of debilitating pain at the global, regional, and
Administration and Control. Available from: https://www. country levels. J Pain Symptom Manag. 2013;45(4):681-700.
nafdac.gov.ng [Last accessed on 2024 Apr 10].
doi: 10.1016/j.jpainsymman.2012.03.011
55. National Drug Law Enforcement Agency. Available
from: https://www.ndlea.gov.ng/about [Last accessed on 65. McCabe S, West B, Boyd C. Leftover prescription opioids
2024 Apr 10]. and nonmedical use among high school seniors: A multi-
cohort national study. J Adolesc Health. 2013;52(4):480-485.
56. Donnelly J, Saldutti E, Gavin L, Hecht M. Public health
implications: A scoping review of opioid prevention doi: 10.1016/j.jadohealth.2012.08.007
programs among adolescents. Med Res Arch. 2023;11:72.
66. Evans R, Widman L, Javidi H, et al. Preliminary evaluation
doi: 10.18103/MRA.v11i7.2.4153 of a prescription opioid misuse prevention program
among rural middle school students. J Commun Health.
57. Pius S. Drug misuse and health implication for the Nigerian
federation of catholic students (secondary school and 2020;45(6):1139-1148.
university) in Maiduguri diocese “for lent season”. Afr J doi: 10.1007/s10900-020-00899-5
Psychol Stud Soc Issues. 2017;20:8.
67. McCabe S, West B, Boyd C. Motives for medical misuse
58. McElrath K, Joseph H. Medication-assisted treatment of prescription opioids among adolescents. J Pain.
(MAT) for opioid use disorder: Introduction to the special 2013;14(10):1208-1216.
issue. Substitute Misuse. 2018;53(2):177-180.
doi: 10.1016/j.jpain.2013.05.004
doi: 10.1080/10826084.2017.1404106
68. Hall E, Cernasev A, Nasritdinova U, Veve M. The stigma
59. Miles J, Howell J, Sheridan D, Braucht G, Mericle A. of opioid use disorder and its indirect effects on student
Supporting individuals using medications for opioid pharmacists’ perceptions and attitudes. Pharmacy.
use disorder in recovery residences: Challenges and 2020;8(3):144.
opportunities for addressing the opioid epidemic. Am J
Drug Alcohol Misuse. 2020;46(3):266-272. doi: 10.3390/pharmacy8030144
doi: 10.1080/00952990.2020.1719410 69. Cepeda M, Coplan P, Kopper N, Mazière J, Wedin G,
Wallace L. Er/la opioid analgesics rems: An overview of
60. Bauder MA. Barriers to rural treatment of opioid use disorder ongoing assessments of its progress and its impact on health
and alcoholism. J Alcohol Drug Depend. 2018;6(4):318. outcomes. Pain Med. 2016;18(1):78-85.
doi: 10.4172/2329-6488.1000318 doi: 10.1093/pm/pnw129
61. Tarter RE, Cochran G, Reynolds M. Prevention of opioid 70. McCabe S, Veliz P, Schulenberg J. Adolescent context of
use disorder. Commonwealth. 2018;20(2-3):39-60. exposure to prescription opioids and substance use disorder
doi: 10.15367/com.v20i2-3.187 symptoms at age 35: A national longitudinal study. Pain.
2016;157(10):2173-2178.
62. Webster PC. Tracking opioid use is vital to avoiding the
scourge. Can Med Assoc J. 2012;184(2):E129-E130. doi: 10.1097/j.pain.0000000000000624
Volume 8 Issue 1 (2025) 58 doi: 10.36922/itps.3894

